|Brand name(s), other common name(s)||Rituxan®|
|Drug type||Monoclonal antibody|
|How the drug is given||Intravenously (IV)|
Rituximab is a monoclonal antibody. It is FDA approved alone or with other medications to treat people who have certain types of non-Hodgkin lymphoma.
Side effects needing medical attention:Fever; chills; difficulty breathing or shortness of breath; sensation of tongue or throat swelling; hives; itching; weakness; headache; nausea; vomiting; flushing; palpitations; chest pain; rash; dizziness; coughing; unusual tiredness or fatigue; unusual bruising or bleeding; muscle or joint pain; abdominal pain; diarrhea.
In patients with prior hepatitis B (HBV) infection, HBV reactivation may occur when the body's immune system is impaired.
Side effects needing medical attention after stopping this medication: Black, tarry stools; blood in urine or stools; painful or difficult urination; pinhead-sized red spots on skin; unusual bleeding or bruising; unusual tiredness or weakness.